Financials
Financial year 2025
DR. LEOVIGILDO CONDE TUMBARELL, algemene geneeskunde from Lubbeek, company number BE0889686968, closed financial year 2025 with a result of € 79,794 after tax. For that financial year DR. LEOVIGILDO CONDE TUMBARELL, algemene geneeskunde recorded a gross margin of € 103,749 and equity of € 831,882. Compared with financial year 2024, the result moved from € 87,176 to € 79,794. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 831,882
▲ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 79,794
▼ 8% vs 2024
Profit after tax over the fiscal year.
€ 613,011
▲ 56% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 813,282.
People and assets in 2025
€ 37,789
▼ 2% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 41
Supplier invoices still open on the last day of the fiscal year.
€ 9,371
▼ 28% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 99,858 | € 109,496 | € 119,070 | € 103,749 | ▼ 13% |
| Profit after taxes | € 72,079 | € 79,737 | € 87,176 | € 79,794 | ▼ 8% |
| Equity | € 632,233 | € 711,970 | € 752,088 | € 831,882 | ▲ 11% |
| Total debts | € 21,234 | € 14,492 | € 62,533 | € 26,938 | ▼ 57% |
| Cash | € 454,602 | € 526,409 | € 393,730 | € 613,011 | ▲ 56% |
| Retained profit | € 613,633 | € 693,370 | € 733,488 | € 813,282 | ▲ 11% |
| Dividend | € 0 | € 0 | € 47,059 | € 0 | ▼ 100% |
| Balance sheet total | € 653,468 | € 726,463 | € 814,621 | € 858,819 | ▲ 5% |
Key figures of DR. LEOVIGILDO CONDE TUMBARELL, algemene geneeskunde, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DR. LEOVIGILDO CONDE TUMBARELL, algemene geneeskunde?
What happened at DR. LEOVIGILDO CONDE TUMBARELL, algemene geneeskunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 79,794 (▼ 8% vs 2024). filed late Source: NBB ↗
- Leo Conde Tumbarell became a director. NBB
- New establishment in Lubbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 72,079 profit in 2022 to € 79,794 profit in 2025.
Paid € 114,496 in corporate taxes since 2022.
Best year ever: 2024, with € 87,176 profit.
Paid out € 47,059 in dividends to the owners in total.
Management
Behind DR. LEOVIGILDO CONDE TUMBARELL, algemene geneeskunde is Leo Conde Tumbarell.
Directors
According to the 2025 annual accounts
Leo Conde Tumbarell
Manager
since 2007
Establishments
Establishment units
Physical locations of this company
Koetsiersweg(LIN) 35
3210 Lubbeek
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0889.686.968
- VAT number
- BE 0889.686.968
- Registered office
- Koetsiersweg(LIN) 35, 3210 Lubbeek
- Names & denominations
- DR. LEOVIGILDO CONDE TUMBARELL, algemene geneeskunde
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 16 May 2007
- Peppol
- Active · Active since 10 Apr 2025